- Home
- KYMR vs ALE Comparison
KYMR vs ALE Comparison
Compare KYMR & ALE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- ALE
- Stock Information
- Founded
- KYMR 2015
- ALE 1906
- Country
- KYMR United States
- ALE United States
- Employees
- KYMR N/A
- ALE N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- ALE Power Generation
- Sector
- KYMR Health Care
- ALE Utilities
- Exchange
- KYMR Nasdaq
- ALE Nasdaq
- Market Cap
- KYMR 4.2B
- ALE 3.8B
- IPO Year
- KYMR 2020
- ALE N/A
- Fundamental
- Price
- KYMR $56.83
- ALE $67.31
- Analyst Decision
- KYMR Strong Buy
- ALE
- Analyst Count
- KYMR 17
- ALE 0
- Target Price
- KYMR $61.65
- ALE N/A
- AVG Volume (30 Days)
- KYMR 910.5K
- ALE 909.9K
- Earning Date
- KYMR 10-30-2025
- ALE 10-29-2025
- Dividend Yield
- KYMR N/A
- ALE 4.34%
- EPS Growth
- KYMR N/A
- ALE N/A
- EPS
- KYMR N/A
- ALE 3.17
- Revenue
- KYMR $44,711,000.00
- ALE $1,532,500,000.00
- Revenue This Year
- KYMR $62.11
- ALE $2.24
- Revenue Next Year
- KYMR N/A
- ALE $5.63
- P/E Ratio
- KYMR N/A
- ALE $21.23
- Revenue Growth
- KYMR N/A
- ALE N/A
- 52 Week Low
- KYMR $19.45
- ALE $62.38
- 52 Week High
- KYMR $59.00
- ALE $67.44
- Technical
- Relative Strength Index (RSI)
- KYMR 65.68
- ALE 75.53
- Support Level
- KYMR $54.09
- ALE $63.72
- Resistance Level
- KYMR $59.00
- ALE $67.44
- Average True Range (ATR)
- KYMR 2.39
- ALE 0.44
- MACD
- KYMR 0.30
- ALE 0.34
- Stochastic Oscillator
- KYMR 80.00
- ALE 96.64
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About ALE Allete Inc.
ALLETE Inc provides competitively-priced energy in America's Upper Midwest region and invests in transmission infrastructure and other energy-centric businesses. The company has two reportable segments. The first segment is Regulated Operations, which includes the company's regulated utilities, Minnesota Power and SWL&P, as well as its investment in ATC. ATC is a regulated utility based in Wisconsin that owns and maintains electric transmission assets in parts of Wisconsin, Michigan, Minnesota, and Illinois. The second segment is ALLETE Clean Energy, which focuses on developing, acquiring, and operating clean and renewable energy projects.